IP Library › Assignment 069774/0091
Patent Assignment
Reel/Frame 069774/0091

Assignment of Assignor's Interest

Recorded: 2025-01-07 Pages: 4
Assignor
EVOTEC (FRANCE) SAS
Executed: 2024-11-20
Assignee
EVOTEC INTERNATIONAL GMBH
ESSENER BOGEN 7, HAMBURG, 22419, GERMANY
Covered Properties (2)
Novel Compounds, Compositions, and Therapeutic Uses Thereof
Application: 18/600,352 →
Publication: US 2024/0327430
Dna Polymerase Theta Inhibitor for Treatment of Cancer
Application: 18/600,365 →
Publication: US 2024/0327431
Related Assignments (6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 9, 2024
From: HOLLICK, JONATHAN
To: BREAKPOINT THERAPEUTICS GMBH
Reel/Frame 068524/0523 →
Assignment of Assignor's Interest Sep 9, 2024
From: HOLLICK, JONATHAN
To: BREAKPOINT THERAPEUTICS GMBH
Reel/Frame 068525/0337 →
Assignment of Assignor's Interest Jan 7, 2025
From: MALASSIS, JULIEN GILBERT JACQUES
To: EVOTEC (FRANCE) SAS
Reel/Frame 069774/0056 →
Assignment of Assignor's Interest Jan 7, 2025
From: CORELLA, ANDREA GUERRERO; FLANAGAN, STUART ROBERT; SMITH, MATTHEW RAYMOND; YULE, IAN ANDREW
To: EVOTEC (UK) LIMITED
Reel/Frame 069774/0063 →
Assignment of Assignor's Interest Jan 7, 2025
From: EVOTEC (UK) LIMITED
To: EVOTEC INTERNATIONAL GMBH
Reel/Frame 069774/0137 →
Assignment of Assignor's Interest Jan 7, 2025
From: EVOTEC INTERNATIONAL GMBH
To: BREAKPOINT THERAPEUTICS GMBH
Reel/Frame 069774/0141 →